×
About 1,995 results

ALLMedicine™ Ecstasy Center

Research & Reviews  675 results

Associations between MDMA/ecstasy use and physical health in a U.S. population-based su...
https://doi.org/10.1177/02698811221127318
Journal of Psychopharmacology (Oxford, England); Jones G, Ricard JA et. al.

Oct 4th, 2022 - 3,4-Methylenedioxymethamphetamine (MDMA/"ecstasy") is an empathogen that can give rise to increased pleasure and empathy and may effectively treat post-traumatic stress disorder. Although prior research has demonstrated associations between ecstas...

Development and initial validation of an MDMA/Ecstasy motives assessment.
https://doi.org/10.1016/j.addbeh.2022.107494
Addictive Behaviors; Sottile JE, Macia KS et. al.

Sep 27th, 2022 - MDMA/Ecstasy motives differ from those of other substances such as alcohol, cannabis, and methamphetamine. Previous literature on alcohol and cannabis use identified social, expansion, enhancement, coping, and conformism as primary motives for use...

Triangulating Amsterdam's illicit stimulant use trends by wastewater analysis and recre...
https://doi.org/10.1016/j.forsciint.2022.111449
Forensic Science International; Ter Laak TL, Emke E et. al.

Sep 24th, 2022 - Drug consumption estimates are of relevance because of public health effects as well as associated criminal activities. Wastewater analysis of drug residues enables the estimation of drug consumption and drug markets. Short-term and long-term tren...

White matter alterations in chronic MDMA use: Evidence from diffusion tensor imaging an...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486575
NeuroImage. Clinical; Zimmermann J, Friedli N et. al.

Sep 21st, 2022 - 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy") is a serotonin- and noradrenaline-releasing substance, currently among the most widely used illicit substances worldwide. In animal studies, repeated exposure to MDMA has been associated with den...

Impact of the use of illicit and licit substances and anxiety disorders on the academic...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484241
BMC Medical Education; Ferreira PM, Alves RJR et. al.

Sep 20th, 2022 - Medical students have a considerable prevalence of anxiety and substance use disorders. Our aim was to assess the presence of anxiety disorders and the use of alcohol and licit and illicit substances, and their influence on the academic performanc...

see more →

Clinicaltrials.gov  29 results

Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects
https://clinicaltrials.gov/ct2/show/NCT05523401

Aug 31st, 2022 - 2C-B is a phenethylamine and belongs to the so-called 2C drugs, a group of novel psychoactive substances (NPS) with some structural similarity to the classic psychedelic mescaline. 2C-B is relatively widely used as recreational substance often rep...

Abuse Potential and Human Pharmacology of Methylone
https://clinicaltrials.gov/ct2/show/NCT05488171

Aug 8th, 2022 - Methylone is a synthetic cathinone that has been popularized as an alternative to other illegal psychostimulants as methylenedioxymethamphetamine (MDMA, ecstasy) or mephedrone. Chemically, methylone is a beta-keto analogue of ecstasy with similar ...

Randomized, Double-blind, Controlled of MDMA-assisted Psychotherapy in 12 Subjects With PTSD
https://clinicaltrials.gov/ct2/show/NCT01958593

Jul 11th, 2022 - Post traumatic stress disorder (PTSD) is a debilitating disorder that can develop after people experience a traumatic event, such as a rape, car accident or other life threatening event. PTSD is a worldwide health problem. PTSD is treated with psy...

Stanford Regulating Circuits of the Brain Study - MDMA
https://clinicaltrials.gov/ct2/show/NCT04060108

Apr 14th, 2022 - The investigators will assess the effect of acute MDMA modulation on the functioning of reward-related human brain circuits. Reward-related brain circuits will be assessed using functional magnetic resonance imaging. Participants will include volu...

Effects of MDMA-like Substances in Healthy Subjects
https://clinicaltrials.gov/ct2/show/NCT04847206

Dec 23rd, 2021 - 3,4-methylenedioxymethamphetamine (MDMA) is used as recreational substance (Ecstasy), research tool to stimulate serotonin (5-HT) and oxytocin release and study associated mood states, and as a potential therapeutic substance to enhance psychother...

see more →

News  93 results

What Ketamine and Psilocybin Can and Cannot Do in Depression
https://www.medscape.com/viewarticle/979294

Aug 16th, 2022 - Recent studies with hallucinogens have raised hopes for an effective drug-based therapy to treat chronic depression. At the German Congress of Psychosomatic Medicine and Psychotherapy, Torsten Passie, MD, PhD, professor of psychiatry and psychothe...

Ann Shulgin, Pioneer of Psychedelics in Therapy, Dies at 91
https://www.medscape.com/viewarticle/977109

Jul 13th, 2022 - Ann Shulgin at her home "The Farm," in Lafayette, Calif.ornia, in 1979. SAN FRANCISCO (AP) — Ann Shulgin, who together with her late husband Alexander Shulgin pioneered the use of psychedelic drugs in psychotherapy and co-wrote two seminal books o...

Cannabis Use Has Risen With Legalization and COVID Lockdowns: UN Report
https://www.medscape.com/viewarticle/976220

Jun 28th, 2022 - VIENNA (Reuters) - Places including U.S. states that have legalized cannabis appear to have increased its regular use, while COVID lockdowns had a similar effect, raising the risk of depression and suicide, a U.N. report said on Monday. Cannabis h...

Government Seeks Advice on Making Nitrous Oxide Possession a Crime
https://www.medscape.com/viewarticle/958108

Sep 3rd, 2021 - The Government is seeking advice on whether to make possession of 'laughing gas' a crime. The Home Office has asked the independent Advisory Council on the Misuse of Drugs (ACMD) to review the harm caused by nitrous oxide. It is acting following w...

California Delays Decriminalizing Psychedelic Substances
https://www.medscape.com/viewarticle/957396

Aug 27th, 2021 - SACRAMENTO, Calif. (AP) — California lawmakers will wait until next year to consider decriminalizing psychedelics, with the bill's author saying Thursday that he will keep working to persuade the public and legislators that it's a good idea. The b...

see more →

Patient Education  1 results see all →